Evidence map›Paper›PMID 36135827›Full record

ArticleMedicines (Basel, Switzerland)2022

Chest X-ray Features in Drug-Resistant Tuberculosis Patients in Nigeria; a Retrospective Record Review.

Olanrewaju Oladimeji, Adenike Temitope Adeniji-Sofoluwe, Yasir Othman, Victor Abiola Adepoju, Kelechi Elizabeth Oladimeji, Bamidele Paul Atiba, Felix Emeka Anyiam, Babatunde A Odugbemi, Tolulope Afolaranmi, Ayuba Ibrahim Zoakah

Open access · goldAbstract read
In one paragraph

Article in Medicines (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Olanrewaju OladimejiDepartment of Public Health, Faculty of Health Sciences, Walter Sisulu University, Mthatha 5099, South Africa.ORCID 0000-0002-5356-901X
Adenike Temitope Adeniji-SofoluweDepartment of Radiology, College of Medicine, University College Hospital Ibadan, University of Ibadan, Ibadan 200132, Nigeria.
Yasir OthmanDepartment of Medicine, Hull University Teaching Hospitals NHS Trust, Hall University, Hull HU3 2JZ, UK.
Victor Abiola AdepojuDepartment of HIV and Infectious Diseases, Jhpiego (An Affiliate of John Hopkins University), Abuja 900271, Nigeria.ORCID 0000-0001-8379-1001
Kelechi Elizabeth OladimejiDepartment of Public Health, Faculty of Health Sciences, Walter Sisulu University, Mthatha 5099, South Africa.ORCID 0000-0002-0246-5595
Bamidele Paul AtibaFaculty of Health Sciences, Durban University of Technology, Durban 4001, South Africa.
Felix Emeka AnyiamFaculty of Health Sciences, Durban University of Technology, Durban 4001, South Africa.ORCID 0000-0003-2774-7406
Babatunde A OdugbemiDepartments of Community Health & Primary Health Care, Lagos State University College of Medicine, Ikeja 102212, Nigeria.ORCID 0000-0001-7551-4450
Tolulope AfolaranmiDepartment of Community Medicine, University of Jos, Jos 930105, Nigeria.ORCID 0000-0002-2764-7002
Ayuba Ibrahim ZoakahDepartment of Community Medicine, University of Jos, Jos 930105, Nigeria.ORCID 0000-0003-1856-7753
University of Jos · NGDurban University of Technology · ZALagos State University · NGUniversity of Abuja · NGUniversity of Hull · GBUniversity of Ibadan · NGWalter Sisulu University · ZA

Funding

Partnership for Global Health Research Training Program (Renewal)-Supplement for OBSSR, NCI, NCI-AIDS and NIDCDD43TW010543 · FIC · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Wafaie W Fawzi, DAVIDSON HOWES HAMER · 2017 to 2026
$12.1M
FIC NIH HHS D43 TW010543NIH HHS D43 TW010543
6 · The paper itself

Abstract

Chest X-ray (CXR) characteristics of patients with drug-resistant tuberculosis (DR-TB) depend on a variety of factors, and therefore, identifying the influence of these factors on the appearance of DR-TB in chest X-rays can help physicians improve diagnosis and clinical suspicion. Our aim was to describe the CXR presentation of patients with DR-TB and its association with clinical and demographic factors. A retrospective analysis of the CXRs of DR-TB patients in Nigeria between 2010 and 2016 was performed, reviewing features of chest radiographs, such as cavitation, opacity and effusion, infiltration and lung destruction. The association of these abnormal CXR findings with clinical and demographic characteristics was evaluated using bivariate and multivariate models, and a p-value < 0.05 was considered statistically significant with a 95% confidence interval. A total of 2555 DR-TB patients were studied, the majority (66.9%) were male, aged 29−38 years (36.8%), previously treated (77%), from the South West treatment zone (43.5%), HIV negative (76.7%) and bacteriologically diagnosed (89%). X-ray findings were abnormal in 97% of the participants, with cavitation being the most common (41.5%). Cavitation, effusion, fibrosis, and infiltration were higher in patients presenting in the South West zone and in those previously treated for DR-TB, while lung destruction was significantly higher in patients who are from the South South zone, and in those previously treated for DR-TB. Patients from the South East zone (AOR: 6.667, 95% CI: 1.383−32.138, p = 0.018), the North East zone (AOR: 6.667, 95% CI: 1.179−37.682, p = 0.032) and the North West zone (AOR: 6.30, 95% CI: 1.332−29.787, p = 0.020) had a significantly increased likelihood of abnormal chest X-ray findings, and prior TB treatment predisposed the patient to an increased likelihood of abnormal chest X-ray findings compared to new patients (AOR: 8.256, 95% CI: 3.718−18.330, p = 0.001). The finding of a significantly higher incidence of cavities, effusions and fibrosis in DR-TB patients previously treated could indicate late detection or presentation with advanced DR-TB disease, which may require a more individualized regimen or surgical intervention.

Indexed as

chest X-raydrug-resistant TBhuman immunodeficiency virustreatment zone

Identifiers

PMID36135827
PMCPMC9504772
OpenAlexW4294839243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.